等待开盘 11-18 09:30:00 美东时间
-0.058
-14.22%
Profusa, Inc. ((Profusa, NASDAQ:PFSA) ("Profusa"), a digital health company pioneering next-generation biosensor technologies, announced progress towards satisfaction of the conditions to close the Option Agreement (the "Agreement") with G3 Vision Labs, Inc. (together with its consolidated subsidiar...
11-12 20:36
Profusa announced progress toward closing its Option Agreement with G3 Vision Labs, including receipt of G3's audited financials for FY2024 and FY2025, and unaudited six months ended June 30, 2026. G3 reported FY2025 revenue of $108 million and Adjusted EBITDA of $5.0 million. Profusa regained compliance with Nasdaq listing standards, exchanged $10.7 million in debt for Preferred Stock, borrowed $0.7 million for working capital, and is progressin...
11-12 12:30
Profusa ( ($PFSA) ) has provided an announcement. Profusa, Inc. and NorthView S...
11-07 06:05
Providing a Foundational Quality Management System (QMS) for Commercialization Certificate issued by GMED, an EU MDR notified body, following the positive certification decision previously announced ISO 13485 certification supports ongoing MDR conformity assessment activities for the Lumee Oxygen Pl...
10-15 18:33
An update from Profusa ( ($PFSA) ) is now available. On October 15, 2026, Profu...
10-15 18:27
Profusa, Inc. has received ISO 13485:2016 certification from GMED, an EU MDR notified body, for its Lumee Oxygen Platform. This certification supports MDR conformity assessment activities and is a key step toward CE marking, enabling commercial distribution in the European Union. The certification also aligns with FDA's updated QMSR framework. The Lumee Oxygen Platform, designed for continuous tissue oxygen monitoring, is a core part of Profusa's...
10-15 10:30
The latest update is out from Profusa ( ($PFSA) ). On October 4, 2026, Profusa ...
10-05 18:29
Profusa shares are trading higher after the company announced it received a positive decision from GMED regarding certification of its quality management system to ISO 13485.
09-24 20:49
Profusa, Inc. has received a positive decision from GMED for ISO 13485 certification of its quality management system, supporting the Lumee® Oxygen Platform's MDR conformity assessment. The company is progressing toward CE marking, indicating compliance with EU safety and health standards. The Lumee platform enables continuous tissue oxygen monitoring, aiding clinical decision-making. Profusa continues to work with GMED to complete remaining MDR ...
09-24 11:30
The latest announcement is out from Profusa ( ($PFSA) ). On September 16, 2026,...
09-16 18:42